Learn More
Medchemexpress LLC Nanatinostat | 1256448-47-1 | 99.7% | 394.40 | C20H19FN6O2 | 5 MG

Supplier: Medchemexpress LLC HY134325MG
Nanatinostat is a second-generation hydroxamic acid-based inhibitor of class I histone deacetylases (HDAC1/2/3). It is orally bioavailable, shows low-nanomolar potency and selectivity, induces apoptosis in cancer cells, and is supplied for research use as a high-purity solid or as a DMSO solution.
- Provides potent inhibition of HDAC1, HDAC2, and HDAC3 at low-nanomolar concentrations.
- Exhibits reduced activity against HDAC5 and HDAC6, improving selectivity.
- Induces apoptosis and antiproliferative effects in cancer cell models.
- Suitable for in vitro and in vivo epigenetic and anticancer studies.
- Available as a high-purity solid and as a DMSO solution for flexible dosing.
- High purity supports reproducible biochemical and cell-based assays.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.